NFA
OXFD

Nationwide Fund Advisors’s Oxford Immunotec Global PLC Ordinary Shares OXFD Stock Holding History

Nationwide Fund Advisors’s Portfolio OXFD Stock Details OXFD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-12,689
Closed -$213K – 2603
2017
Q3 		$213K Hold
12,689
– – ﹤0.01% 2610
2017
Q2 		$213K Sell
12,689
-1,076
-8% -$16.1K ﹤0.01% 2609
2017
Q1 		$213K Buy
13,765
+254
+2% +$3.63K ﹤0.01% 2552
2016
Q4 		$202K Hold
13,511
– – ﹤0.01% 2594
2016
Q3 		$170K Hold
13,511
– – ﹤0.01% 2706
2016
Q2 		$122K Hold
13,511
– – ﹤0.01% 2839
2016
Q1 		$134K Hold
13,511
– – ﹤0.01% 2711
2015
Q4 		$155K Buy
13,511
+635
+5% +$7.86K ﹤0.01% 2665
2015
Q3 		$174K Hold
12,876
– – ﹤0.01% 2640
2015
Q2 		$178K Buy
12,876
+2,890
+29% +$39.1K ﹤0.01% 2766
2015
Q1 		$141K Buy
9,986
+32
+0.3% +$436 ﹤0.01% 2860
2014
Q4 		$136K Buy
9,954
+134
+1% +$1.83K ﹤0.01% 2821
2014
Q3 		$150K Buy
9,820
+175
+2% +$2.68K ﹤0.01% 2831
2014
Q2 		$162K Buy
9,645
+4,878
+102% +$87.8K ﹤0.01% 2844
2014
Q1 		$96K Hold
4,767
– – ﹤0.01% 2748
2013
Q4 		$92K Buy
+4,767
New +$84.3K ﹤0.01% 2980

Other funds holding OXFD

Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
PC
Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return

Nationwide Fund Advisors's OXFD Position: Q4 2017 in Review

Nationwide Fund Advisors sold out of Oxford Immunotec Global PLC Ordinary Shares (OXFD) in Q4 2017, closing a stake of 12,689 shares — an estimated $213K sold.

Nationwide Fund Advisors first reported a position in OXFD in Q4 2013 and held it in 16 quarters. The position peaked at $213K in Q3 2017. 77 funds tracked by Wall St. Rank hold OXFD as of Q4 2017.

  • Nationwide Fund Advisors reported no remaining Oxford Immunotec Global PLC Ordinary Shares position as of Q4 2017 after selling out during the quarter.
  • Nationwide Fund Advisors sold 12,689 Oxford Immunotec Global PLC Ordinary Shares shares in Q4 2017, an estimated $213K.
  • Nationwide Fund Advisors first reported a position in Oxford Immunotec Global PLC Ordinary Shares in Q4 2013 and held it in 16 quarters.
  • Nationwide Fund Advisors's Oxford Immunotec Global PLC Ordinary Shares position peaked at $213K in Q3 2017.
  • 77 funds tracked by Wall St. Rank held Oxford Immunotec Global PLC Ordinary Shares as of Q4 2017.

Based on Nationwide Fund Advisors's 13F filing for Q4 2017, filed 1 Feb 2018.